Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
CANO.US
id: 500

Cano Health after-M&A-talks Sell Off Case

On December 7, 2022, Bloomberg reported that Daniel Loeb’s Third Point sold its stake in Cano Health Inc. (CANO) amid mounting concerns about the healthcare provider’s liquidity.

Further, BBG reported that some of Cano Health’s biggest creditors are in the early stages of organizing ahead of potential debt discussions.

Earlier, after CANO reported weaker Q3 results and revised full-year guidance, multiple equity analysts cut their ratings on the Company. Cano had $24 million of cash on hand, down from roughly $163 million at the end of last year.

Going back to September 22, 2022, The Wall Street Journal reported that CVS Health and Humana were in talks to buy out Cano. Since then, there's been no solid news about the matter, so it rises questions about whether these deals were on agenda at all.

Taking all the facts into account, Investors have all grounds to suspect that multiple violations took place starting from misleading statements, stock price manipulations, and fraud.
Case Status
Attorney Investigation
Alleged Offence
Mismanagement
Misleading Statements
Financial Misrepresentation
Fraud
Failure to Disclose
Price manipulation
Insider Trading
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Suspected Party
Directors
Management
Shareholder
Influencer
Investment Bank
Service Provider
Hedge Fund
Security Type
Stocks
Trade Direction
Long
Shock Event Date
12/07/2022
Collecting participants…